Literature DB >> 3267365

Multiple symmetric lipomatosis.

M S Lee1, M H Lee, K B Hur.   

Abstract

Multiple symmetric lipomatosis (MSL) is an extremely uncommon disorder. In the medical literatures about 200 cases have been reported. MSL is not associated with other generalized lipomatous disorders, nor are these patient to be necessarily obese. The cause of MSL is unknown. The disorder usually occurs in middle-aged males and there is frequently a history of alcoholism. Some instances of familial occurrence have been reported, but the majority of cases are sporadic. Two cases of MSL are presented.

Entities:  

Mesh:

Year:  1988        PMID: 3267365      PMCID: PMC3053672          DOI: 10.3346/jkms.1988.3.4.163

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  5 in total

Review 1.  Benign fatty tumors: classification, clinical course, imaging appearance, and treatment.

Authors:  Laura W Bancroft; Mark J Kransdorf; Jeffrey J Peterson; Mary I O'Connor
Journal:  Skeletal Radiol       Date:  2006-08-23       Impact factor: 2.199

2.  Madelung disease: A case report.

Authors:  Hui Gao; Zhi-Ying Xin; Xin Yin; Yu Zhang; Qing-Long Jin; Xiao-Yu Wen
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

3.  Benign symmetric lipomatosis (Madelung's disease) with concomitant incarcerated femoral hernia: A case report.

Authors:  Bo Li; Zheng-Xing Rang; Jia-Cong Weng; Guo-Zuo Xiong; Xian-Peng Dai
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

4.  Diagnostic and surgical challenges of progressive neck and upper back painless masses in Madelung's disease: A case report and review of literature.

Authors:  Ya-Jie Yan; Shi-Qing Zhou; Chun-Qiao Li; Yan Ruan
Journal:  World J Clin Cases       Date:  2022-01-07       Impact factor: 1.337

5.  Madelung's disease in a non-alcoholic Ethiopian male patient mistaken for obesity: a case report.

Authors:  Yared Zenebe Zewde
Journal:  BMC Endocr Disord       Date:  2021-07-03       Impact factor: 2.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.